PhotoBioModulation

Introducing PhotoBioModulation: A Breakthrough in Dry Macular Degeneration Treatment

We are excited to bring incredible news to patients in Wilmington and South Eastern North Carolina—a revolutionary treatment for dry age-related macular degeneration (AMD) is now available at Paul Vision Institute. PhotoBioModulation (PBM) therapy, offers new hope for managing dry AMD. Already widely used in Europe, this innovative treatment is now improving lives here in the United States.

Clinical studies have shown that PBM can enhance vision, reduce drusen deposits, and help prevent the progression of geographic atrophy with consistent use. For those struggling with vision loss caused by dry macular degeneration, this groundbreaking therapy offers an exciting opportunity for better retinal health.

If you or a loved one is living with dry AMD, don’t wait—this could be the solution you’ve been searching for.

What Is Dry Macular Degeneration?

Dry macular degeneration is one of the leading causes of vision loss in individuals over 50. As this condition progresses, it causes retinal atrophy and the formation of blind spots in central vision, which can grow larger over time. The effects on everyday tasks, like reading, driving, or recognizing loved ones’ faces, can be life-changing.

While lifestyle changes and AREDS2 supplements, like TOZAL,  may help slow the disease’s progression, no treatment has been available to actively restore and protect vision — until now.

How Does PBM Work?

PBM is an innovative treatment that uses precise wavelengths of red and infrared light to address the cellular processes involved in dry macular degeneration (AMD). PBM stimulates mitochondrial activity, supports healthy cell metabolism, and helps reduce inflammation and cell death. This advanced therapy works to slow the progression of dry AMD, improve vision, and even decrease drusen—the small yellow deposits that build up in the retina.

Clinical Benefits of PBM

In clinical trials, patients who underwent photobiomodulation (PBM) therapy experienced:

1. Improved visual acuity, with an average gain of more than one line on the eye chart after one and two years of treatment.
2. Reduced drusen volume, decreasing the macular deposits associated with vision loss.
3. Slowed progression of geographic atrophy, with significantly fewer cases of this condition in treated patients compared to those receiving a sham treatment.

These clinical findings are an exciting step forward, offering patients with dry macular degeneration (AMD) a proven option to maintain vision and slow disease progression.

Treatment Details

PBM uses a cutting-edge light delivery system to emit red and infrared light. The treatment is non-invasive, safe, and performed through multiple sessions over a few weeks.

1. Treatment Schedule: Most patients complete a series of 9 treatment sessions over 3-5 weeks. After the initial series, follow-up treatments are typically scheduled every 4 months.
2. No Pain: PBM is well-tolerated, with most patients reporting no pain or discomfort during the procedure.

Is PBM Right for You?

PBM is an excellent option for patients with dry macular degeneration (AMD) who have drusen or non-central geographic atrophy. However, this treatment is not recommended for individuals with wet AMD or for those who have advanced vision loss caused by central macular atrophy.

Looking for Macular Degeneration Treatment in Wilmington, NC?

Contact the Paul Vision Institute today at (910) 256-6364 to schedule an appointment with an experienced optometrist near you.